Patent · US Active

Combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event

US8163504B2 · kind B2 · utility

1Cited by
1References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateOct 2, 2009
Grant dateApr 24, 2012
Priority date
Expiry dateOct 2, 2029

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/50
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method of identifying a subject having or at risk of having or developing a cardiovascular disease and/or a cardiovascular event, includes:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.